Health atai Life Sciences Announces Results from the Kures Globe News Wire Dec 24, 2022 - This two-part phase 1 trial in healthy volunteers was designed to assess the safety, pharmacokinetics, and analgesic activity of KUR-101 - KUR-101 was well tolerated and demonstrated analgesic activity in two experimental pain…